Top News and Analysis for R&D and Executive Leaders

Week of 5.7.08

Click here to
submit entries

About PharmaWeek
Rocked by massive drug withdrawals, charges of greed and dishonesty, exploding pipelines, and a proliferation of regulations, the pharmaceutical industry has reached a tipping point. Big changes are coming—it’s just not clear what they will be.

Pharmaceutical industry professionals and the many other businesses that work with them are faced with two often conflicting challenges: Finding ways to work more efficiently while also accommodating drastic changes.

One solution: Keep up with key industry developments and gain valuable insights through Cambridge Healthtech Institute (CHI)’s new e-newsletter PharmaWeek. Our new e-newsletter provides a top-line look at the week’s events in the pharmaceutical world and surrounding arenas. PharmaWeek also delivers weekly exclusive analysis on major trends, key strategies, leading executives, and general business as well as career advice.

All subscribers receive each week’s top news overall, which also contains one exclusive article. In addition, you can personalize your edition of PharmaWeek to contain top news articles from any or all of the following special topic areas:

• Business and Markets: Includes business strategy, deals, financial news, product milestones, executive moves, and events influencing pricing and market size or dynamics. The emphasis is on news or insights that influence business decisions. Topics can be related to discovery, development, manufacturing or marketing of drugs, diagnostics, and medical devices.

• Personalized Medicine: Includes targeted therapeutics, certain diagnostics, theranostics, pharmacogenomics, pharmacogenetics, and any developments that promote or impede personalized medicine (also known as individualized therapy).

• Regulatory and Legal: Includes developments within regulatory agencies or changes in laws, as well as lawsuits and rulings. Provides an international perspective on these developments but focuses on major developments. 

• Technology Platforms: Includes technology platform launches, proof-of-concept studies, comparative evaluations, major deals, and new internal initiatives.

PharmaWeek is published by Cambridge Healthtech Institute (CHI) and builds upon the knowledge base CHI creates in producing approximately 60 life sciences conferences per year. The newsletter is currently available on a free trial basis. Visit our homepage at www.PharmaWeek.com or contact us at editor@pharmaweek.com